Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503. https://doi.org/10.1212/WNL.0b013e31827f0fd1

Article  PubMed  PubMed Central  Google Scholar 

Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259. https://doi.org/10.1007/bf00308809

CAS  Article  PubMed  Google Scholar 

Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16:271–278. https://doi.org/10.1016/0197-4580(95)00021-6 (discussion 278-284)

CAS  Article  PubMed  Google Scholar 

Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20–38. https://doi.org/10.1002/ana.23937

CAS  Article  PubMed  PubMed Central  Google Scholar 

Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CH et al (2018) Immune-related genetic enrichment in frontotemporal dementia: an analysis of genome-wide association studies. PLoS Med 15:e1002487. https://doi.org/10.1371/journal.pmed.1002487

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P et al (2014) TREM2 variant p. R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol 71:449–453. https://doi.org/10.1001/jamaneurol.2013.6237

Article  PubMed  PubMed Central  Google Scholar 

Cho H, Kim HJ, Choi JY, Ryu YH, Lee MS, Na DL et al (2019) (18)F-flortaucipir uptake patterns in clinical subtypes of primary progressive aphasia. Neurobiol Aging 75:187–197. https://doi.org/10.1016/j.neurobiolaging.2018.11.017

CAS  Article  PubMed  Google Scholar 

Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM et al (2017) Consensus classification of posterior cortical atrophy. Alzheimers Dement 13:870–884. https://doi.org/10.1016/j.jalz.2017.01.014

Article  PubMed  PubMed Central  Google Scholar 

Deczkowska A, Weiner A, Amit I (2020) The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell 181:1207–1217. https://doi.org/10.1016/j.cell.2020.05.003

CAS  Article  PubMed  Google Scholar 

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K et al (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13:614–629. https://doi.org/10.1016/S1474-4422(14)70090-0

Article  PubMed  Google Scholar 

Ghezzi L, Carandini T, Arighi A, Fenoglio C, Arcaro M, De Riz M et al (2017) Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation. Neurology 89:2503–2505. https://doi.org/10.1212/wnl.0000000000004747

CAS  Article  PubMed  Google Scholar 

Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006–1014. https://doi.org/10.1212/WNL.0b013e31821103e6

Article  PubMed  PubMed Central  Google Scholar 

Gratuze M, Leyns CE, Sauerbeck AD, St-Pierre MK, Xiong M, Kim N et al (2020) Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J Clin Invest 130:4954–4968. https://doi.org/10.1172/jci138179

CAS  Article  PubMed  PubMed Central  Google Scholar 

Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E et al (2013) TREM2 variants in Alzheimer’s disease. N Engl J Med 368:117–127. https://doi.org/10.1056/NEJMoa1211851

CAS  Article  PubMed  Google Scholar 

Haass C (2021) Loss of TREM2 facilitates tau accumulation, spreading, and brain atrophy, but only in the presence of amyloid pathology. Neuron 109:1243–1245. https://doi.org/10.1016/j.neuron.2021.03.029

CAS  Article  PubMed  Google Scholar 

Hassan A, Whitwell JL, Josephs KA (2011) The corticobasal syndrome-Alzheimer’s disease conundrum. Expert Rev Neurother 11:1569–1578. https://doi.org/10.1586/ern.11.153

Article  PubMed  PubMed Central  Google Scholar 

Hickman SE, El Khoury J (2014) TREM2 and the neuroimmunology of Alzheimer’s disease. Biochem Pharmacol 88:495–498. https://doi.org/10.1016/j.bcp.2013.11.021

CAS  Article  PubMed  Google Scholar 

Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K et al (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer’s disease and dementia with Lewy bodies. Brain Res 1184:284–294. https://doi.org/10.1016/j.brainres.2007.09.048

CAS  Article  PubMed  Google Scholar 

Jellinger KA (2020) Pathobiological subtypes of Alzheimer disease. Dement Geriatr Cogn Disord 49:321–333. https://doi.org/10.1159/000508625

Article  PubMed  Google Scholar 

Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D et al (2014) Coding variants in TREM2 increase risk for Alzheimer’s disease. Hum Mol Genet 23:5838–5846. https://doi.org/10.1093/hmg/ddu277

CAS  Article  PubMed  PubMed Central  Google Scholar 

Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J et al (2013) Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med 368:107–116. https://doi.org/10.1056/NEJMoa1211103

CAS  Article  PubMed  Google Scholar 

Joshi P, Riffel F, Kumar S, Villacampa N, Theil S, Parhizkar S et al (2021) TREM2 modulates differential deposition of modified and non-modified Abeta species in extracellular plaques and intraneuronal deposits. Acta Neuropathol Commun 9:168. https://doi.org/10.1186/s40478-021-01263-x

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kannarkat GT, Cook DA, Lee JK, Chang J, Chung J, Sandy E et al (2015) Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson’s disease: an observational and case-control study. NPJ Parkinsons Dis. https://doi.org/10.1038/npjparkd.2015.2

Article  PubMed  PubMed Central  Google Scholar 

Korvatska O, Leverenz JB, Jayadev S, McMillan P, Kurtz I, Guo X et al (2015) R47H variant of TREM2 associated with Alzheimer disease in a large late-onset family: clinical, genetic, and neuropathological study. JAMA Neurol 72:920–927. https://doi.org/10.1001/jamaneurol.2015.0979

Article  PubMed  PubMed Central  Google Scholar 

Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65–78. https://doi.org/10.1007/s00401-017-1679-9

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH et al (2021) Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology. Neuron 109:1283-1301.e1286. https://doi.org/10.1016/j.neuron.2021.02.010

CAS  Article  PubMed  Google Scholar 

Li R, Wang X, He P (2021) The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer’s disease: a systematic review and meta-analysis. Exp Ther Med 21:347. https://doi.org/10.3892/etm.2021.9778

CAS  Article  PubMed  PubMed Central  Google Scholar 

Liesinger AM, Graff-Radford NR, Duara R, Carter RE, Hanna Al-Shaikh FS, Koga S et al (2018) Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease. Acta Neuropathol 136:873–885. https://doi.org/10.1007/s00401-018-1908-x

Article  PubMed  PubMed Central  Google Scholar 

Luis EO, Ortega-Cubero S, Lamet I, Razquin C, Cruchaga C, Benitez BA et al (2014) Frontobasal gray matter loss is associated with the TREM2 p. R47H variant. Neurobiol Aging 35:2681–2690. https://doi.org/10.1016/j.neurobiolaging.2014.06.007

CAS  Article  PubMed  PubMed Central  Google Scholar 

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89:88–100. https://doi.org/10.1212/WNL.0000000000004058

Article  PubMed  PubMed Central  Google Scholar 

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National institute on aging-Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11. https://doi.org/10.1007/s00401-011-0910-3

CAS  Article  PubMed  Google Scholar 

Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785–796. https://doi.org/10.1016/S1474-4422(11)70156-9

Article  PubMed  PubMed Central  Google Scholar 

Nasrallah IM, Chen YJ, Hsieh M-K, Phillips JS, Ternes K, Stockbower GE et al (2018) (18)F-Flortaucipir PET/MRI correlations in nonamnestic and amnestic variants of Alzheimer disease. J Nucl Med 59:299–306. https://doi.org/10.2967/jnumed.117.194282

CAS  Article  PubMed  PubMed Central  Google Scholar 

Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142:1503–1527. https://doi.org/10.1093/brain/awz099

Article  PubMed  PubMed Central